Technology News and Research

RSS

MEDSEEK expands relationship with Frederick Memorial to develop eHealth ecoSystem

MEDSEEK, the leading provider of healthcare enterprise portal connectivity solutions, announced today the expansion of its relationship with long-time partner Frederick Memorial with its engagement to develop the healthcare organization's comprehensive eHealth ecoSystem.TM

30 Mar 2010

Emory Institute of Drug Discovery and Zirus collaborate to develop new anti-viral drugs

The Emory Institute of Drug Discovery and Zirus, Inc., a biotechnology company based in Buford, Georgia, have entered into a collaboration and research agreement to develop novel compounds to treat infectious disease. Zirus uses a proprietary method for identifying genes and gene products in host cells that, when blocked, can prevent viruses from multiplying. Over the past several years, either alone or in collaboration with partners, including the Centers for Disease Control and Prevention (CDC), Zirus has identified, licensed and filed patents on more than 1000 targets.

30 Mar 2010

New home health provisions proposed in Health Care Reform Bill to benefit older patients

New home health provisions proposed in the Health Care Reform Bill (H.R. 3590 Patient Protection and Affordable Care Act) will support the testing and implementation of in-home health care services for chronically ill elderly residents of Greater Philadelphia.

30 Mar 2010

Dicerna Pharmaceuticals, Ipsen announce collaboration in DsiRNA research and peptide engineering

Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company, and Ipsen, a global biotechnology specialty care group, announced today that the two companies have entered into an exclusive research collaboration agreement to leverage their expertise in Dicer Substrate siRNA (DsiRNA) research and peptide engineering. The companies will develop novel conjugates of Dicerna's DsiRNA molecules and Ipsen's peptide targeting vectors in the therapeutic areas of oncology and endocrinology.

30 Mar 2010

Royal Philips Electronics introduces InnerCool RTx Endovascular System

Royal Philips Electronics announced today its launch of the Philips InnerCool RTx Endovascular System for cooling and warming, which provides advanced whole body temperature modulation therapy in a closed-loop system from the inside out. The InnerCool RTx is a high-performance system that can rapidly raise and lower the body temperature of certain non-paralyzed, awake patients of all sizes in the intensive care setting.

From Philips Healthcare 30 Mar 2010

Adoption of healthcare IT is on steady incline in small physician practice: NaviNet survey

Adoption of healthcare IT is on a steady incline in the small physician practice, reveals a survey by NaviNet, America's largest real-time healthcare communications network. In early March 2010, NaviNet conducted a survey of IT and electronic medical record adoption trends in small practices and compared results to a similar survey the company issued to small practices in August 2009.

30 Mar 2010

Enrollment complete in Paradigm Spine's comparative study of coflex interlaminar technology

Paradigm Spine, LLC, a developer of innovative non-fusion and fusion spinal implant solutions, announced today that it has completed patient enrollment in an Investigational Device Exemption pivotal clinical study comparing the coflex® interlaminar technology to instrumented posterolateral fusion in the surgical treatment of spinal stenosis.

30 Mar 2010

LCT receives approval for New Zealand Phase II human trial of DIABECELL

Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, today announced that it has received approval to advance to the next phase of its New Zealand Phase II human clinical trial with its groundbreaking DIABECELL®. The approval follows a positive assessment from the New Zealand Data Safety and Monitoring Board of the first four patients to receive its DIABACELL® implants.

30 Mar 2010

DIATHERIX GI test panel can detect nine types of GI infections

DIATHERIX Laboratories adds a gastrointestinal panel to its lineup of highly sensitive, rapid response diagnostic tests. In a single result, the DIATHERIX GI panel can detect and differentiate nine types of GI infections so physicians can quickly identify patients who have severe, life-threatening infections.

30 Mar 2010

GenVec announces discontinuation of TNFerade PACT trial for pancreatic cancer

GenVec, Inc. announced today that it is discontinuing its Phase 3 clinical trial of TNFerade™ in patients with locally advanced pancreatic cancer based on results of an interim analysis. This interim analysis of overall survival, conducted after the 184th death (two-thirds of total expected events), was designed to determine whether the study should continue.

30 Mar 2010

NexMed files IND with FDA for Phase II trial of PrevOnco for HCC

NexMed, Inc, a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the Company has filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) for a Phase II trial of its recently acquired cancer drug candidate PrevOnco™, in combination with doxorubicin in patients with advanced, unresectable hepatocellular carcinoma (HCC). The FDA has 30 days to comment on the IND before NexMed can proceed with human testing.

29 Mar 2010

National Institute of Mental Health awards two-year, $998,940 grant for autism research

An average of one in 100 children in the United States has an autism spectrum disorder according to the Centers for Disease Control and Prevention. While over the last few years an increasing number of these children have begun to receive early intervention services, research shows that high quality and intensive intervention are critical for positive outcomes.

29 Mar 2010

Eclipsys, Rothman partner to build Patient Condition Tracker software solution on Helios by Eclipsys platform

Following the momentum of launching an industry-defining open architecture platform, Eclipsys Corporation today announced a partnership with Rothman Healthcare Research to build its Patient Condition Tracker software solution on the Helios by Eclipsys™ platform.

29 Mar 2010

Prolucent Workforce Management acquires intellectual property assets from Symbio Solutions

Prolucent™ Workforce Management, the leading partner for healthcare providers seeking to optimize deployment of their workforce, today announced the acquisition of intellectual property assets from Symbio Solutions, Inc. The asset acquisition further strengthens Prolucent's best-of-breed workforce management software platform and will help Prolucent deliver even greater value to the more than 1,000 acute-care hospitals and staffing agencies it currently serves.

29 Mar 2010

FDA grants SynCardia Systems conditional approval to conduct IDE study of Freedom driver system

SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.

29 Mar 2010

Chakra Biotech completes MYR18.2m Series B investment round

Chakra Biotech Sdn Bhd, a Malaysian based Contract Research Organization, has completed a MYR18.2m Series B funding round. This brings total funding for the company to MYR20.0m. Malaysian Life Sciences Capital Fund Ltd. (MLSCF) and the Malaysian Technology Development Corporation Sdn Bhd (MTDC) participated in the round.

29 Mar 2010

Oxygen Biotherapeutics commences distributing newly formulated Dermacyte Oxygen Concentrate

Oxygen Biotherapeutics, Inc. today announced that the company has begun distribution for its newly formulated Dermacyte™ Oxygen Concentrate for the beauty and skin care market. The over-the-counter product is a scientifically designed perfluorocarbon concentrate to enhance oxygen delivery to skin.

29 Mar 2010

Positive results from Pearl Therapeutics' Phase 1 study of inhaled combination bronchodilator for COPD

Pearl Therapeutics Inc., a company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from a Phase 1 safety and pharmacokinetics study of PT003, its lead combination therapeutic for the treatment of chronic obstructive pulmonary disease (COPD). Based on these results, and previously announced positive results from Phase 2a studies of PT003's individual components, the company has advanced PT003 into a Phase 2b trial.

29 Mar 2010

GEA Niro selects engineering simulation software from ANSYS

GEA Niro has selected engineering simulation software from ANSYS to optimize equipment design and reduce development time and costs. Based in Denmark, GEA Niro is a world market leader in drying technology for the dairy, food, pharmaceutical and chemical industries and is a core technology center in the GEA Process Engineering business segment in GEA Group.

29 Mar 2010

Three new hospitals utilize PureWellness' comprehensive online employee wellness platform

PureWellness, Inc., a leading provider of online wellness solutions, announced it has signed agreements with three new hospitals; Northeast Georgia Health Systems, McCullough-Hyde Memorial Hospital, and Fletcher Allen Health Care.

29 Mar 2010

Technology News and Research

MEDSEEK expands relationship with Frederick Memorial to develop eHealth ecoSystem

Emory Institute of Drug Discovery and Zirus collaborate to develop new anti-viral drugs

New home health provisions proposed in Health Care Reform Bill to benefit older patients

Dicerna Pharmaceuticals, Ipsen announce collaboration in DsiRNA research and peptide engineering

Royal Philips Electronics introduces InnerCool RTx Endovascular System

Adoption of healthcare IT is on steady incline in small physician practice: NaviNet survey

Enrollment complete in Paradigm Spine's comparative study of coflex interlaminar technology

LCT receives approval for New Zealand Phase II human trial of DIABECELL

DIATHERIX GI test panel can detect nine types of GI infections

GenVec announces discontinuation of TNFerade PACT trial for pancreatic cancer

NexMed files IND with FDA for Phase II trial of PrevOnco for HCC

National Institute of Mental Health awards two-year, $998,940 grant for autism research

Eclipsys, Rothman partner to build Patient Condition Tracker software solution on Helios by Eclipsys platform

Prolucent Workforce Management acquires intellectual property assets from Symbio Solutions

FDA grants SynCardia Systems conditional approval to conduct IDE study of Freedom driver system

Chakra Biotech completes MYR18.2m Series B investment round

Oxygen Biotherapeutics commences distributing newly formulated Dermacyte Oxygen Concentrate

Positive results from Pearl Therapeutics' Phase 1 study of inhaled combination bronchodilator for COPD

GEA Niro selects engineering simulation software from ANSYS

Three new hospitals utilize PureWellness' comprehensive online employee wellness platform

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News